Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2005
12/22/2005US20050282802 double salts of N-(3-Methyl-benzylidene)-N'-[6-morpholin-4-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-hydrazine, having improved bioavailability, solubility, melting point and stability, used for the treatment of interleukin-12 (IL-12) related diseases or disorders
12/22/2005US20050282796 Tetracyclic azepinoindole compounds
12/22/2005US20050282779 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes
12/22/2005US20050282778 Combining 1-monoacyldipyrromethane with a boron compound to produce a metal complex
12/22/2005DE102004025552A1 New 2-amino-imidazo(4,5-d)pyridazin-4-one derivatives are dipeptidyl-peptidase IV inhibitors useful in the treatment of e.g. diabetes mellitus, autoimmune disease, rheumatoid arthritis, and multiple sclerosis
12/22/2005CA2727841A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2, 3-d] pyrimidine derivatives and related compounds
12/22/2005CA2569910A1 Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds
12/22/2005CA2569675A1 Cationic bacteriochlorophyll derivatives and uses thereof
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568722A1 Pyrazolo pyrimidines
12/22/2005CA2568389A1 Hiv integrase inhibitors
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1607091A1 Antihepatitis c virus agent and anti-hiv agent
12/21/2005EP1606291A2 Efficient synthesis of pyropheophorbide a and its dervatives
12/21/2005EP1606283A2 P38 inhibitors and methods of use thereof
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols
12/21/2005EP1606243A1 Process for the preapaation of chiral beta amino acid derivatives by asymmetric hydrogenation
12/21/2005EP1605761A1 Synergistically acting herbicidal mixtures
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1289995B1 Fungicidal triazolopyrimid-7-ylideneamines
12/21/2005CN1711269A 4-amino-5-phenyl-7-cyclohexyl-pyrrolo[2,3-d]pyrimidine derivatives
12/21/2005CN1711268A 2-mercapto-substituted triazolopyrimidines, methods for the production thereof, the use of the same for controlling patogenic fungi, and agents containing said compounds
12/21/2005CN1711267A 2-substituted triazolopyrimidines, methods and intermediate products for the production thereof, the use of the same for controlling pathogenic fungi, and agents containing said compounds
12/21/2005CN1711266A Pyrimido compounds having antiproliferative activity
12/21/2005CN1711265A Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
12/21/2005CN1711264A Pyrimido[4,5-d]pyrimidine derivatives with anticancer activity
12/21/2005CN1711263A 5-alkyl-7-aminotriazolopyrimidines, methods and intermediary product necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms
12/21/2005CN1709893A Method for preparing 2-arylamino-6H-imidazo[1,2-b]-1,2,4-triazole-6-ketone and its sterilizing activity
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232505C Substituted sulfamide (thio) carbonyl compounds
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977263 Chemical compounds
12/20/2005US6977254 For prevention and/or suppression of preterm labor, suppression labor at term prior to caesarean deliver, and for the treatment of dysmenorrhea, useful in enhancing fertility rates
12/20/2005CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/20/2005CA2328903C Compounds capable of cleaving double-stranded dna and method of utilization of the same
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/15/2005WO2005119794A1 Materials for photoelectric conversion devices and photoelectric conversion devices
12/15/2005WO2005118591A1 Condensed piperidine compounds acting as adrenergic receptor antagonists useful in the treatment of prostatic hyperplasia and lower urinary symptoms
12/15/2005WO2005118590A1 Bicyclic heterocycles as hiv integrase inhibitors
12/15/2005WO2005118589A1 Bicyclic heterocycles as hiv integrase inhibitors
12/15/2005WO2005118588A1 Fused heterocyclic compound
12/15/2005WO2005118587A1 Indole derivative and use for treatment of cancer
12/15/2005WO2005118549A2 Compounds having affinity for dopamine d3 receptor and uses thereof
12/15/2005WO2005118544A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118532A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
12/15/2005WO2005117909A2 Kinase modulators and methods of use
12/15/2005WO2005117904A2 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005WO2005117894A1 Leptomycin compounds
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005WO2005117868A1 Tetrahydrocarboline antiviral agents
12/15/2005WO2005102323A3 Process of preparing esters and ethers of probucol and derivatives thereof
12/15/2005WO2005097768A3 Novel gamma secretase inhibitors
12/15/2005WO2005071096A3 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample
12/15/2005WO2005065266A3 Di-substituted pyrrolotriazine compounds
12/15/2005WO2005017124A3 Peptide deformylase inhibitors
12/15/2005WO2005011597A8 Compounds and compositions as protein kinase inhibitors
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005US20050277773 Pyrrolopyrimidine derivatives
12/15/2005US20050277770 condensing a 5-acetaldipyrromethane with a dipyrromethane-1,9-dicarbinol to produce a porphyrin having an acetal group substituted thereon at the 5 position; and then hydrolyzing said porphyrin to produce said 5-formylporphyrin
12/15/2005US20050277658 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
12/15/2005US20050277655 Pyrazolopyrimidines
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277643 N-(4-tert-Butyl-phenyl)-[7-(3-chloro-pyridin-2-yl)-2-methoxymethyl-5,6,7,8-tetrahydro-pyrido[3,4-d]pyrimidin-4-yl]-amine; antiinflammatory agents treating pain, inflammation, traumatic injury, arthritis, Parkinson's disease, Alzheimer's disease, stroke, asthma, myocardial infarction
12/15/2005US20050277639 2-Pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
12/15/2005US20050277119 Substituted azaporphyrins as fluorescence labels
12/15/2005CA2568836A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2568341A1 Leptomycin compounds
12/15/2005CA2566531A1 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005CA2563699A1 Kinase modulators and method of use
12/15/2005CA2562713A1 Phosphonate analogs of hiv integrase inhibitor compounds
12/14/2005EP1604991A1 Antitumor effect potentiator and antitumor agent
12/14/2005EP1604653A1 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
12/14/2005EP1603918A1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
12/14/2005EP1603917A1 Immunomodulating heterocyclic compounds
12/14/2005EP1603916A1 Enantiomerically pure cilazapril, process for preparation
12/14/2005EP1603915A1 SUBSTITUTED 8 -PYRIDINYL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE AND 8 -PYRIMIDIN YL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES
12/14/2005EP1603914A1 Compounds having activity at 5ht2c receptor and uses thereof
12/14/2005EP1603913A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
12/14/2005EP1603910A1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
12/14/2005EP1603896A2 Cxcr3 antagonists
12/14/2005CN1708500A Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and use as inhibitor of the interaction of CAMs and leukointegrins
12/14/2005CN1708493A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1706844A Metal porphyrin nanotube and nanoline and their prepn process
12/14/2005CN1706843A Temozolomide refining process
12/14/2005CN1231488C Metallocenyl phthalocyanines dye
12/13/2005US6974868 A 6-(7-((2-(phenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2, 3-triazolo(4,5-d)pyrimidin-3-yl)-tetrahydro-2,2-dimethyl-4H-cyclopentane-1,2-diol derivative; anticoagulants; myocardial infarction, strokes; thrombolytic and antiischemic agents;
12/13/2005US6974823 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
12/13/2005US6974819 Alzheimer's disease; Parkinson's disease; Pick's disease; bipolar disorders; schizophrenia; alopecia; anticancer agents
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005US6974668 antitumor agent binds to base DNA or RNA sequence; measure cytolysis of tumor cells; drug screening
12/13/2005CA2314571C Methods and compositions for treating diseases and conditions of the eye
12/13/2005CA2171003C Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo[1,2,4]triazolo[1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation
12/08/2005WO2005116035A1 Pyrrolopyrimidine derivatives useful in cancer treatment
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 573